Clinical Trial Update: Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF). [Phase 4]

View source ↗

Summary

This document provides the results of a Phase 4 trial comparing augmented versus normal renal replacement therapy in patients with acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: The George Institute | Conditions: Acute Renal Failure | Phase 4 | Status: COMPLETED